Peter Richmond mainly focuses on Immunology, Vaccination, Immunogenicity, Virology and Microbiology. His works in Antibody, Innate immune system, Immune system, Serotype and Avidity are all subjects of inquiry into Immunology. His research in Vaccination intersects with topics in Titer, Adverse effect, Immunization, Seroconversion and Pediatrics.
His Immunogenicity research is multidisciplinary, incorporating elements of Neisseria meningitidis, Meningococcal vaccine, Orthomyxoviridae and Adjuvant. His Virology study combines topics from a wide range of disciplines, such as Reactogenicity, Conjugate vaccine and Meningococcal disease. His research on Microbiology also deals with topics like
His primary areas of study are Immunology, Vaccination, Pediatrics, Virology and Internal medicine. His Immunology research is multidisciplinary, relying on both Haemophilus influenzae and Streptococcus pneumoniae. Peter Richmond interconnects Adverse effect and Immunization, Reactogenicity in the investigation of issues within Vaccination.
The concepts of his Pediatrics study are interwoven with issues in Epidemiology, Cohort study, Incidence, Disease and Prospective cohort study. His work deals with themes such as Gastroenterology and Placebo, which intersect with Internal medicine. His Immunogenicity research integrates issues from Neisseria meningitidis and Meningococcal vaccine.
Peter Richmond focuses on Vaccination, Internal medicine, Immunology, Pediatrics and Diphtheria. His Vaccination study incorporates themes from Adverse effect, Seroconversion, Incidence and Reactogenicity. As part of the same scientific family, Peter Richmond usually focuses on Internal medicine, concentrating on Immunogenicity and intersecting with Transplantation, Influenza vaccine, Institutional review board, Oncology and Clinical trial.
Pertussis vaccine, Antibody, Immune system, Immune Dysfunction and Vaccine response are among the areas of Immunology where the researcher is concentrating his efforts. Peter Richmond has researched Pediatrics in several fields, including Readmission risk, Hospital readmission, Risk factor and Hazard ratio. His studies in Diphtheria integrate themes in fields like Antigen, Immunoassay, Vaccine-preventable diseases, Poliomyelitis and Conjugate vaccine.
His scientific interests lie mostly in Vaccination, Internal medicine, Odds ratio, Seroconversion and Influenza vaccine. He combines subjects such as Relative risk, Pediatrics and Reactogenicity with his study of Vaccination. His Internal medicine study integrates concerns from other disciplines, such as Meningococcal carriage and MENINGOCOCCAL B.
Peter Richmond has included themes like Neisseria meningitidis, Meningococcal disease, Randomized controlled trial, Group B and Invasive group in his Odds ratio study. His Seroconversion research incorporates themes from Adjuvant, Placebo, Adverse effect and Immunogenicity. His study on Adjuvant is covered under Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effects of probiotics on atopic dermatitis: a randomised controlled trial
Stephanie Weston;Anne R Halbert;Peter Richmond;Susan L Prescott.
Archives of Disease in Childhood (2005)
Meningococcal Serogroup C Conjugate Vaccine Is Immunogenic in Infancy and Primes for Memory
Peter Richmond;Ray Borrow;Elizabeth Miller;Sarah Clark.
The Journal of Infectious Diseases (1999)
Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory after a Single Dose in UK Toddlers
Peter Richmond;Ray Borrow;David Goldblatt;Jamie Findlow.
The Journal of Infectious Diseases (2001)
Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.
Terry Nolan;Jodie McVernon;Maryanne Skeljo;Peter Richmond.
Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.
Keith Cartwright;Rhonwen Morris;Hans Rümke;Andrew Fox.
Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal‐Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1
S. W. Knight;N. S. Heiss;T. J. Vulliamy;C. M. Aalfs.
British Journal of Haematology (1999)
Innate immunity in human newborn infants: prematurity means more than immaturity.
Tobias Strunk;Andrew Currie;Peter Richmond;Karen Simmer.
Journal of Maternal-fetal & Neonatal Medicine (2011)
Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.
David Goldblatt;Jo Southern;Lindsey Ashton;Peter Richmond.
Pediatric Infectious Disease Journal (2006)
Meningococcal C Polysaccharide Vaccine Induces Immunologic Hyporesponsiveness in Adults That Is Overcome by Meningococcal C Conjugate Vaccine
Peter Richmond;Ed Kaczmarski;Ray Borrow;Jamie Findlow.
The Journal of Infectious Diseases (2000)
Clinical effects of probiotics are associated with increased interferon‐γ responses in very young children with atopic dermatitis
Susan Prescott;Janet Dunstan;J. Hale;L.A. Breckler.
Clinical & Experimental Allergy (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: